[Bilateral uveitis intermedia. A 15-year clinical course].
Ayertey
H D
HD
Zentrum für Augenheilkunde, Universität zu Köln. helen.ayertey@gmx.de
Jordan
J F
JF
Walter
P
P
Brunner
R
R
D000328:Adult; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors; D015867:Uveitis, Intermediate / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D014792:Visual Acuity; D014821:Vitrectomy
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D005448:Fluocortolone; D016899:Interferon-beta; D001379:Azathioprine